No headlines found.
No press releases found.
No news found.
Virtus LifeSci Biotech Products ETF (the "Products Fund") is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.
Virtus Lifesci Biotech Products ETF trades on the ARCA stock market under the symbol BBP.
As of January 6, 2026, BBP stock price climbed to $79.90 with 4,662 million shares trading.
BBP has a market cap of $43.95 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BBP traded as high as $82.63 and as low as $45.00.
BBP has outperformed the market in the last year with a return of +30.8%, while the SPY ETF gained +18.1%. In the last 3 month period, BBP beat the market returning +11.1%, while SPY returned +3.7%. However, in the most recent 2 weeks BBP has underperformed the stock market by returning -2.3%, while SPY returned +1.0%.
BBP support price is $78.11 and resistance is $80.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBP shares will trade within this expected range on the day.
